Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Sturge-Weber Syndrome 2Neoplasms 2Nausea 2Marijuana Abuse 2Colonic Neoplasms 2Anxiety Disorders 2Vomiting 1Solid Tumor 1Parasomnias 1Pain 1Glioblastoma 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Cachexia 1Breast Carcinoma In Situ 1Breast Cancer Female 1Arthralgia 1Appetitive Behavior 1

Interventions

Letrozole 4Anastrozole 4Surveys and Questionnaires 3Aromatase Inhibitors 3exemestane 2Exercise 2Educational Status 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1Yoga 1Walking 1Vitamin B 12 1Therapeutics 1Testosterone 1Tamoxifen 1Occupational Therapy 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Gabapentin 1Fish Oils 1Fatty Acids, Omega-3 1Docosahexaenoic Acids 1Diphosphonates 1Diet Therapy 1Denosumab 1Curcumin 1Chondroitin Sulfates 1Chondroitin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthralgia × Cannabidiol × Clear all
NCT04754399 2025-05-09

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

University of Michigan Rogel Cancer Center

Phase 2 Completed
40 enrolled 10 charts
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡